Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis

Cancer Genetics and Cytogenetics

Volumn 146, Issue 2, 2003, Pages 145-153

  Tibiletti, Maria Grazia ^a   Bernasconi, Barbara ^a   Taborelli, Monica ^a   Facco, Carla ^a   Riva, Cristina ^a   Capella, Carlo ^a   Franchi, Massimo ^a   Binelli, Giorgio ^b   Acquati, Francesco ^b   Taramelli, Roberto ^b  

^a OSPEDALE DI CIRCOLO   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 21; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 6Q; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME DELETION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; EPITHELIUM TUMOR; FEMALE; GENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; OVARY TUMOR; PRIORITY JOURNAL; TUMOR MODEL; X CHROMOSOME;

EID: 0141750566     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00134-1     Document Type: Article

References (29)

1. Herbst A.L. The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. Am J Obstet Gynecol. 170:1994;1105-1107.
2. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
3. Scully R.E. Histological typing of ovarian tumours. 2nd ed. 1999;Springer-Verlag, Berlin.
4. Teneriello M.G., Ebina M., Linnoila R.I., Henry M., Nash J.D., Park R.C., Birrer M.J. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 53:1993;3103-3108.
5. Wertheim I., Muto M.G., Welch W.R., Bell D.A., Berkowitz R.S., Mok S.C. p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst. 86:1994;1549-1551.
6. Cheng P.C., Gosewehr J.A., Kim T.M., Velicescu M., Wan M., Zheng J., Felix J.C., Cofer K.F., Luo P., Biela B.H., Godorov G., Dubeau L. Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J Natl Cancer Inst. 88:1996;510-518.
7. Wang V.W., Bell D.A., Berkowitz R.S., Mok S.C. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res. 61:2001;4169-4174.
8. Gu J., Roth L.M., Younger C., Michael H., Abdul-Karim F.W., Zhang S., Ulbright T.M., Eble J.N., Cheng L. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst. 93:2001;1147-1152.
9. Ortiz B.H., Ailawadi M., Colitti C., Muto M.G., Deavers M., Silva E.G., Berkowitz R.S., Mok S.C., Gershenson D.M. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 61:2001;7264-7267.
10. Rodabaugh K.J., Blanchard G., Welch W.R., Bell D.A., Berkowitz R.S., Mok S.C. Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res. 55:1995;2169-2172.
11. Wolf N.G., Abdul-Karim F.W., Schork N.J., Schwartz S. Origins of heterogeneous ovarian carcinomas: a molecular cytogenetic analysis of histologically benign, low malignant potential, and fully malignant components. Am J Pathol. 149:1996;511-520.
12. Roy W.J. Jr., Watson R.H., Hitchcock A., Campbell I.G. Frequent loss of heterozygosity on chromosomes 7 and 9 in benign epithelial ovarian tumours. Oncogene. 15:1997;2031-2035.
13. Dodson M.K., Hartmann L.C., Cliby W.A., DeLacey K.A., Keeney G.L., Ritland S.R., Su J.Q., Podratz K.C., Jenkins R.B. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res. 53:1993;4456-4460.
14. Sato N., Tsunoda H., Nishida M., Morishita Y., Takimoto Y., Kubo T., Noguchi M. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 60:2000;7052-7056.
15. Singer G., Kurman R.J., Chang H.W., Cho S.K., Shih Ie M. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol. 160:2002;1223-1228.
16. Tibiletti M.G., Bernasconi B., Furlan D., Riva C., Trubia M., Buraggi G., Franchi M., Bolis P., Mariani A., Frigerio L., Capella C., Taramelli R. Early involvement of 6q in surface epithelial ovarian tumors. Cancer Res. 56:1996;4493-4498.
17. Tibiletti M.G., Bernasconi B., Furlan D., Bressan P., Cerutti R., Facco C., Riva C., Cinquetti R., Capella C., Tarmelli R. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms. Clin Cancer Res. 7:2001;3404-3409.
18. Tibiletti M.G., Trubia M., Ponti E., Sessa L., Acquati F., Furlan D., Bernasconi B., Fichera M., Mihalich A., Ziegler A., Volz A., Facco C., Riva C., Cremonesi L., Ferrari M., Taramelli R. Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involvement in benign surface epithelial ovarian tumours. Oncogene. 16:1998;1639-1642.
19. Greene F.L. American Joint Committee on Cancer; American Cancer Society. AJCC cancer staging manual. 6th edition:2002;Springer, New York.
20. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
21. Pinkel D., Straume T., Gray J.W. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A. 83:1986;2934-2938.
22. de Nictolis M., Montironi R., Tommasoni S., Carinelli S., Ojeda B., Matias-Guiu X., Prat J. Serous borderline tumors of the ovary: a clinicopathologic, immunohistochemical, and quantitative study of 44 cases. Cancer. 70:1992;152-160.
23. Berchuck A., Boente M.P., Kerns B.J., Kinney R.B., Soper J.T., Clarke-Pearson D.L., Bast R.C., Bacus S.S. Ploidy analysis of epithelial ovarian cancers using image cytometry. Gynecol Oncol. 44:1992;61-65.
24. Foulkes W.D., Ragoussis J., Stamp G.W., Allan G.J., Trowsdale J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer. 67:1993;551-559.
25. Orphanos V., McGown G., Hey Y., Thorncroft M., Santibanez-Koref M., Russell S.E., Hickey I., Atkinson R.J., Boyle J. Allelic imbalance of chromosome 6q in ovarian tumours. Br J Cancer. 71:1995;666-669.
26. Cooke I.E., Shelling A.N., Le Meuth V.G., Charnock M.L., Ganesan T.S. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Genes Chromosomes Cancer. 15:1996;223-233.
27. Zheng J., Benedict W.F., Xu H.J., Hu S.X., Kim T.M., Velicescu M., Wan M., Cofer K.F., Dubeau L. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. J Natl Cancer Inst. 87:1995;1146-1153.
28. Scully R.E. Influence of origin of ovarian cancer on efficacy of screening. Lancet. 355:2000;1028-1029.
29. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instability in human cancers. Nature. 396:1998;643-649.